News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
348,112 Results
Type
Article (27665)
Company Profile (147)
Press Release (320292)
Multimedia
Podcasts (34)
Webinars (14)
Section
Business (96498)
Career Advice (1316)
Deals (15697)
Drug Delivery (83)
Drug Development (40057)
Employer Resources (156)
FDA (8399)
Job Trends (8886)
News (162859)
Policy (14537)
Tag
Academia (1980)
Academic (2)
Accelerated approval (6)
Adcomms (17)
Allergies (93)
Alliances (26631)
ALS (89)
Alzheimer's disease (944)
Antibody-drug conjugate (ADC) (86)
Approvals (8497)
Artificial intelligence (239)
Autoimmune disease (21)
Automation (16)
Bankruptcy (109)
Best Places to Work (7410)
BIOSECURE Act (13)
Biosimilars (79)
Biotechnology (87)
Bladder cancer (75)
Brain cancer (25)
Breast cancer (235)
Cancer (1775)
Cardiovascular disease (170)
Career advice (1168)
Career pathing (35)
CAR-T (119)
CDC (19)
Cell therapy (330)
Cervical cancer (17)
Clinical research (33591)
Collaboration (764)
Compensation (337)
Complete response letters (17)
COVID-19 (1380)
CRISPR (52)
C-suite (344)
Cystic fibrosis (97)
Data (2325)
Decentralized trials (1)
Denatured (22)
Depression (53)
Diabetes (233)
Diagnostics (3489)
Digital health (13)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (100)
Drug pricing (68)
Drug shortages (6)
Duchenne muscular dystrophy (94)
Earnings (29894)
Editorial (21)
Employer branding (24)
Employer resources (135)
Events (52233)
Executive appointments (667)
FDA (9782)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (691)
Gene editing (99)
Generative AI (21)
Gene therapy (278)
GLP-1 (450)
Government (2377)
Grass and pollen (2)
Guidances (190)
Healthcare (10121)
HIV (30)
Huntington's disease (20)
IgA nephropathy (36)
Immunology and inflammation (76)
Immuno-oncology (3)
Indications (22)
Infectious disease (1493)
Inflammatory bowel disease (117)
Inflation Reduction Act (9)
Influenza (40)
Intellectual property (79)
Interviews (197)
IPO (6825)
IRA (26)
Job creations (1782)
Job search strategy (1011)
Kidney cancer (2)
Labor market (59)
Layoffs (213)
Leadership (19)
Legal (2619)
Liver cancer (47)
Longevity (10)
Lung cancer (245)
Lymphoma (154)
Machine learning (13)
Management (52)
Manufacturing (284)
MASH (48)
Medical device (6476)
Medtech (6484)
Mergers & acquisitions (9378)
Metabolic disorders (506)
Multiple sclerosis (68)
NASH (11)
Neurodegenerative disease (80)
Neuropsychiatric disorders (14)
Neuroscience (1463)
NextGen: Class of 2025 (3698)
Non-profit (3467)
Now hiring (52)
Obesity (223)
Opinion (145)
Ovarian cancer (63)
Pain (81)
Pancreatic cancer (74)
Parkinson's disease (137)
Partnered (16)
Patents (151)
Patient recruitment (149)
Peanut (47)
People (35511)
Pharmaceutical (40)
Pharmacy benefit managers (4)
Phase I (9606)
Phase II (14398)
Phase III (12419)
Pipeline (1347)
Policy (110)
Postmarket research (1409)
Preclinical (4182)
Press Release (61)
Prostate cancer (90)
Psychedelics (23)
Radiopharmaceuticals (131)
Rare diseases (374)
Real estate (3308)
Recruiting (60)
Regulatory (11239)
Reports (47)
Research institute (1750)
Resumes & cover letters (166)
Rett syndrome (11)
RNA editing (7)
RSV (41)
Schizophrenia (67)
Series A (123)
Series B (80)
Service/supplier (8)
Sickle cell disease (47)
Special edition (9)
Spinal muscular atrophy (110)
Sponsored (27)
Startups (2426)
State (1)
Stomach cancer (8)
Supply chain (36)
Tariffs (14)
The Weekly (12)
Vaccines (412)
Venture capital (47)
Weight loss (133)
Women's health (23)
Worklife (19)
Date
Today (15)
Last 7 days (299)
Last 30 days (1197)
Last 365 days (18128)
2025 (12574)
2024 (20463)
2023 (23022)
2022 (29265)
2021 (32079)
2020 (29557)
2019 (25914)
2018 (19347)
2017 (17189)
2016 (16712)
2015 (18790)
2014 (13768)
2013 (11003)
2012 (11447)
2011 (11774)
2010 (10702)
Location
Africa (495)
Alabama (39)
Alaska (7)
Arizona (110)
Arkansas (10)
Asia (19469)
Australia (3477)
California (4733)
Canada (1349)
China (368)
Colorado (200)
Connecticut (221)
Delaware (173)
Europe (57310)
Florida (762)
Georgia (176)
Hawaii (2)
Idaho (23)
Illinois (353)
India (33)
Indiana (326)
Iowa (16)
Japan (204)
Kansas (52)
Kentucky (21)
Louisiana (12)
Maine (14)
Maryland (598)
Massachusetts (3717)
Michigan (150)
Minnesota (272)
Mississippi (4)
Missouri (57)
Montana (17)
Nebraska (11)
Nevada (60)
New Hampshire (20)
New Jersey (1487)
New Mexico (19)
New York (1383)
North Carolina (802)
North Dakota (9)
Northern California (2156)
Ohio (157)
Oklahoma (8)
Oregon (23)
Pennsylvania (982)
Puerto Rico (10)
Rhode Island (23)
South America (645)
South Carolina (13)
Southern California (1772)
Tennessee (63)
Texas (625)
United States (17738)
Utah (116)
Virginia (117)
Washington D.C. (47)
Washington State (308)
West Virginia (2)
Wisconsin (64)
348,112 Results for "tiziana life sciences plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
September 10, 2025
·
2 min read
Press Releases
FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy
August 12, 2025
·
4 min read
Press Releases
Tiziana Life Sciences to Present at the Bio International Convention
June 16, 2025
·
3 min read
Press Releases
Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer’s Patient
July 22, 2025
·
4 min read
Press Releases
Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy
August 15, 2025
·
4 min read
Press Releases
Tiziana Life Sciences Announces Purchase of Shares by Chairman
May 12, 2025
·
2 min read
Press Releases
Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer’s Disease
May 23, 2025
·
5 min read
Press Releases
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
June 16, 2025
·
3 min read
Press Releases
Tiziana Life Sciences to Present at the 37th Annual Roth Conference
March 18, 2025
·
3 min read
Press Releases
Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis
May 7, 2025
·
7 min read
1 of 34,812
Next
